Waging war against pancreatic cancer: an interview with David Tuveson

Tuveson, D. (April 2017) Waging war against pancreatic cancer: an interview with David Tuveson. Dis Model Mech, 10 (4). pp. 353-357. ISSN 1754-8403

[img]
Preview
PDF (Interview)
Tuveson 2017.pdf - Published Version

Download (295Kb) | Preview
URL: https://www.ncbi.nlm.nih.gov/pubmed/28381597
DOI: 10.1242/dmm.029975

Abstract

David Tuveson, Director of the Cancer Center at Cold Spring Harbor Laboratory, is a clinician-scientist with a longstanding interest in understanding and treating pancreatic cancer. Since developing the first mouse model of pancreatic cancer in 2002, the Tuveson lab has made a series of discoveries that shed light on the molecular drivers of this disease and provide promising therapeutic avenues for a malignancy that is notoriously challenging to treat. In collaboration with Hans Clevers, David developed the first pancreatic cancer organoids, which revolutionized the field by providing a powerful model system for basic discoveries and advancement of personalized medicine. Here, David talks to Ross Cagan about his path from chemistry student to world-renowned oncologist, highlighting how his colleagues, mentors and patient interactions shaped his research interests and unique approach to scientific discovery. As well as discussing the story behind some of his breakthroughs, he provides tips on running a lab and succeeding in or outside academia.

Item Type: Paper
Subjects: educational material
CSHL Authors:
Communities: CSHL labs > Tuveson lab
CSHL Cancer Center Program > Signal Transduction
Depositing User: Matt Covey
Date: 1 April 2017
Date Deposited: 12 Apr 2017 16:03
Last Modified: 13 Jun 2018 16:09
Related URLs:
URI: http://repository.cshl.edu/id/eprint/34471

Actions (login required)

Administrator's edit/view item Administrator's edit/view item
CSHL HomeAbout CSHLResearchEducationNews & FeaturesCampus & Public EventsCareersGiving